Wegovy (semaglutide) is approved for weight management in people with obesity, and adults with overweight who have a weight-related comorbidity such as high cholesterol or type 2 diabetes
G., Critchley H
[DOI] [PMC free article] [PubMed] [Google Scholar] 136.El-Ghannam M.S., Saad M.A., Nassar N.N., El-Yamany M.F., El-Bahy A.A.Z
In the EU, Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults with a BMI of 30 kg/m 2 or greater (obesity) or adults with a BMI of 27 kg/m 2 or greater (overweight) in the presence of at least one weight-related comorbid condition
Grip it, unrack it, keep just a slight bend in your knees, then hinge at the hips push your glutes back and let the bar slide down the front of your legs to around mid-shin
USA 118 , e2012748118 (2021)